Australia markets closed

FSD Pharma Inc. (HUGE)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.3450-0.0040 (-1.15%)
At close: 04:00PM EDT
0.3490 +0.00 (+1.16%)
After hours: 06:53PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 14.52M
Enterprise value 13.05M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)105.03
Price/book (mrq)1.22
Enterprise value/revenue 119.64
Enterprise value/EBITDA -1.57

Trading information

Stock price history

Beta (5Y monthly) 0.99
52-week change 3-67.76%
S&P500 52-week change 326.94%
52-week high 31.6800
52-week low 30.3070
50-day moving average 30.5001
200-day moving average 30.9182

Share statistics

Avg vol (3-month) 3354.98k
Avg vol (10-day) 3611.32k
Shares outstanding 542.1M
Implied shares outstanding 646.67M
Float 834.66M
% held by insiders 116.77%
% held by institutions 13.62%
Shares short (30 Apr 2024) 4334.87k
Short ratio (30 Apr 2024) 41.39
Short % of float (30 Apr 2024) 40.97%
Short % of shares outstanding (30 Apr 2024) 40.83%
Shares short (prior month 28 Mar 2024) 4333.37k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 316 Oct 2019
Ex-dividend date 4N/A
Last split factor 21:201
Last split date 316 Oct 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-43.02%
Return on equity (ttm)-83.91%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -16.73M
Net income avi to common (ttm)-17.9M
Diluted EPS (ttm)-0.2500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.51M
Total cash per share (mrq)0.09
Total debt (mrq)339.2k
Total debt/equity (mrq)2.63%
Current ratio (mrq)2.43
Book value per share (mrq)0.34

Cash flow statement

Operating cash flow (ttm)-10.83M
Levered free cash flow (ttm)-15.51M